Accession Number: | 0001127602-19-032879 |
Date: | 2019-11-14 |
Issuer: | MEDTRONIC PLC (MDT) |
Original Submission Date: |
COYLE MICHAEL J
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2019-11-14 | M | 900 | a | $38.81 | 189,162 | direct | ||
ORDINARY SHARES | 2019-11-14 | S | 900 | d | $109.52 | 188,262 | direct | ||
ORDINARY SHARES | 2019-11-14 | M | 1,202 | a | $41.60 | 189,464 | direct | ||
ORDINARY SHARES | 2019-11-14 | S | 1,202 | d | $109.95 | 188,262 | direct | ||
ORDINARY SHARES | 2019-11-14 | 0 | $0.00 | 250 | indirect | ||||
ORDINARY SHARES | 2019-11-14 | 0 | $0.00 | 4,104 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.81 | 2019-11-14 | deemed execution date | M | 900 (d) | 2022-07-30 | ordinary shares 900 | $38.81 | 36,874 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 41.6 | 2019-11-14 | deemed execution date | M | 1,202 (d) | 2022-10-29 | ordinary shares 1,202 | $41.60 | 0 | direct |
ID | footnote |
---|---|
f1 | the transactions reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan. |
f2 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive. the reporting person undertakes to provide to medtronic plc , any security holder of medtronic plc, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this form 4. |
f3 | this option to purchase 75,548 new medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 75,548 medtronic common stock shares for $38.81 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option. |
f4 | this option to purchase 2,404 new medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 2,404 medtronic common stock shares for $41.60 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option. |